Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 744-757
Closed Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder
Ruben van Boxel, Shiral S. Gangadin, Hella Janssen, et al.
Journal of Psychiatric Research (2023) Vol. 163, pp. 93-101
Open Access | Times Cited: 11
Gamma‐aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment‐resistant schizophrenia: A proton magnetic resonance spectroscopy (1H‐MRS) study
Fumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 76, Iss. 11, pp. 587-594
Closed Access | Times Cited: 18
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes
Jacopo Sapienza, Marta Bosia, Marco Spangaro, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 59-67
Closed Access | Times Cited: 17
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 18, pp. 2035-2052
Closed Access | Times Cited: 17
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
Alice Egerton, Kira Griffiths, Cecila Casetta, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 3, pp. 567-575
Open Access | Times Cited: 17
Medial Frontal Cortex GABA Concentrations in Psychosis Spectrum and Mood Disorders: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies
Molly Simmonite, Clara J. Steeby, Stephan F. Taylor
Biological Psychiatry (2022) Vol. 93, Iss. 2, pp. 125-136
Open Access | Times Cited: 16
Role of the immune-kynurenine pathway in treatment-resistant schizophrenia
Wenjin Chen, Yichang Tian, Mengzhuang Gou, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 130, pp. 110926-110926
Closed Access | Times Cited: 9
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status
Yvonne S. Yang, Jason Smucny, Huailin Zhang, et al.
NeuroImage Clinical (2023) Vol. 39, pp. 103461-103461
Open Access | Times Cited: 8
Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex
Lejia Fan, Liangbing Liang, Yujue Wang, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 5, pp. 845-853
Open Access | Times Cited: 8
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 7
Beyond the γ-aminobutyric acid hypothesis of schizophrenia
Kazuyuki Fujihara
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Prenatal cocaine exposure and its influence on pediatric epigenetic clocks and epigenetic scores in humans
Thiago Wendt Viola, C. S. Danzer, Victor Mardini, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
Kennadi Johnson, Abby J. Weldon, Melissa A. Burmeister
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Parvalbumin Regulates GAD Expression through Calcium Ion Concentration to Affect the Balance of Glu-GABA and Improve KA-Induced Status Epilepticus in PV-Cre Transgenic Mice
Chun-Mei Zeng, Yuling Lu, Xing Wei, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 10, pp. 1951-1966
Closed Access | Times Cited: 2
Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders
Jamie J Lopes, Sean P. Carruthers, Denny Meyer, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 11, pp. 930-951
Open Access | Times Cited: 2
Metabolomics Analysis of the Prefrontal Cortex in a Rat Chronic Unpredictable Mild Stress Model of Depression
Lihua Duan, Rong Fan, Teng Li, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 12
The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration
Sunniva Fenn‐Moltu, J.F.W. Deakin, Richard Drake, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 343-351
Open Access | Times Cited: 6
Synergistic, long-term effects of glutamate dehydrogenase 1 deficiency and mild stress on cognitive function and mPFC gene and miRNA expression
Kfir Asraf, Hiba Zaidan, Baylasan Natoor, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Erbb4Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes
Amanda Kiemes, Maria Elisa Serrano Navacerrada, Eugene Kim, et al.
Schizophrenia Bulletin (2022) Vol. 49, Iss. 3, pp. 569-580
Open Access | Times Cited: 9
A longitudinal investigation of GABA, glutamate, and glutamine across the insula during antipsychotic treatment of first-episode schizophrenia
Susan F. Sonnenschein, Ahmad Mayeli, Victor E. Yushmanov, et al.
Schizophrenia Research (2022) Vol. 248, pp. 98-106
Open Access | Times Cited: 8
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk
L. Prohens, Natàlia Rodríguez, Àlex-González Segura, et al.
Psychiatry Research (2024) Vol. 332, pp. 115722-115722
Open Access | Times Cited: 1
Acute psychosis following baclofen overdose
Khandaker Mostafa, Marlene Kelbrick, Ali Mustafa, et al.
Progress in Neurology and Psychiatry (2024) Vol. 28, Iss. 2, pp. 41-44
Closed Access | Times Cited: 1
Defining the disturbance in cortical glutamate and GABA function in psychosis and its origins and consequences
J.F.W. Deakin, Elizabeth B. Liddle, Mohanbabu Rathnaiah, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Applications of MRI in Schizophrenia: Current Progress in Establishing Clinical Utility
Hui Sun, Naici Liu, Changjian Qiu, et al.
Journal of Magnetic Resonance Imaging (2024)
Closed Access | Times Cited: 1
Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex
Lejia Fan, Zhenmei Zhang, Xiaoqian Ma, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 6, pp. E367-E376
Open Access | Times Cited: 1

Scroll to top